{{Rsnum
|rsid=1061758
|Gene=IL11RA
|Chromosome=9
|position=34652333
|Orientation=plus
|GMAF=0.315
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=IL11RA
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 26.5 | 70.8
| HCB | 11.9 | 50.0 | 38.1
| JPT | 18.6 | 56.6 | 24.8
| YRI | 13.0 | 58.2 | 28.8
| ASW | 10.7 | 41.1 | 48.2
| CHB | 11.9 | 50.0 | 38.1
| CHD | 18.3 | 48.6 | 33.0
| GIH | 8.0 | 30.0 | 62.0
| LWK | 16.4 | 46.4 | 37.3
| MEX | 6.9 | 67.2 | 25.9
| MKK | 21.2 | 50.6 | 28.2
| TSI | 4.9 | 30.4 | 64.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=21982075
|Title=Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}